Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, net loss was USD 0.405061 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9178 USD | -2.37% | -16.56% | -91.66% |
1st Jan change | Capi. | |
---|---|---|
-91.66% | 13.51M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |